Plasma total homocysteine: instigator or indicator of cardiovascular disease?

Ann Clin Biochem 2008;45:345-348
doi:10.1258/acb.2008.008053
© 2008 Association for Clinical Biochemistry

 

This Article
Right arrow
Full Text
Right arrow

Full Text (PDF)

Right arrow
Alert me when this article is cited
Right arrow
Alert me if a correction is posted
Services
Right arrow
Email this article to a friend
Right arrow

Similar articles in this journal

Right arrow

Similar articles in Web of Science

Right arrow
Similar articles in PubMed
Right arrow
Alert me to new issues of the journal
Right arrow
Download to citation manager
Right arrow
Citing Articles
Right arrow
Citing Articles via HighWire
Right arrow

Citing Articles via Web of Science (12)

Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow
Articles by Moat, S. J
Right arrow Search for Related Content
PubMed
Right arrow
PubMed Citation
Social Bookmarking

What’s this?

Personal View


Stuart J Moat


Department of Medical Biochemistry and Immunology, University Hospital of Wales and Wales College of Medicine, Heath Park, Cardiff CF14 4XW, UK


Email: Stuart.moat{at}cardiffandvale.wales.nhs.uk

Cardiovascular disease (CVD) is a major cause of morbidity and mortality in developed countries. However, traditional risk factors cannot fully account for this. In the last 20 years, there has been an explosion of interest in plasma total homocysteine (tHcy) as a potential modifiable risk factor for CVD. Recent meta-analyses of epidemiological studies support the concept that increased tHcy concentrations are associated with CVD. This has led to the ‘homocysteine hypothesis’, which states that lowering plasma tHcy using folic acid and other B-vitamins will reduce the risk of CVD. In experimental studies, homocysteine has been shown to cause oxidative stress, endothelial cell dysfunction and promote thrombogenesis. However, data from recent large randomized controlled trials have shown that there is no clinical benefit to lowering plasma tHcy concentrations with folic acid and other B-vitamins. This lack of effect of tHcy lowering strongly suggests that homocysteine is not an instigator but merely an indicator of CVD.


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What’s this?






This article has been cited by other articles:

Home page Bioscience HorizonsHome page

B. O’Neill
A scientific review of the reported effects of vegan nutrition on the occurrence and prevalence of cancer and cardiovascular disease
Bioscience Horizons,

June 1, 2010;

3(2):

197 – 212.

[Abstract]
[Full Text]
[PDF]